Atomic AI is an early-stage biotech company that fuses artificial intelligence and structural biology. They are transforming the rational design of molecules and medicines to unlock the next generation of RNA-targeted small molecule and RNA-based therapeutics.
- Category
- RNA Drug Discovery
- Stage
- Series A
- Employees
- 30
- HQ
- South San Francisco, United States
- Founded
- 2021
- Funding
- $42M